Evidence map›Paper›PMID 26935107›Full record

ArticleDisease models & mechanisms2016

Mouse myofibers lacking the SMYD1 methyltransferase are susceptible to atrophy, internalization of nuclei and myofibrillar disarray.

M David Stewart, Suhujey Lopez, Harika Nagandla, Benjamin Soibam, Ashley Benham, Jasmine Nguyen, Nicolas Valenzuela, Harry J Wu, Alan R Burns, Tara L Rasmussen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Hsf1 is essential for proteotoxic stress response in smyd1b-deficient embryos and fish survival under heat shock.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  4. Epigenetic control of skeletal muscle atrophy.Cellular & molecular biology letters · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Treatment of chemotherapy-induced cachexia with BST204: a multimodal validation study.Metabolomics : Official journal of the Metabolomic Society · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

M David StewartDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA dstewart@uh.edu.
Suhujey LopezDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.
Harika NagandlaDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.
Benjamin SoibamDepartment of Computer Science and Engineering Technology, University of Houston-Downtown, Houston, TX 77002, USA.
Ashley BenhamStem Cell Engineering Department, Texas Heart Institute at St Luke's Episcopal Hospital, Houston, TX 77030, USA.
Jasmine NguyenDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.
Nicolas ValenzuelaDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.
Harry J WuDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.
Alan R BurnsCollege of Optometry, University of Houston, Houston, TX 77204, USA.
Tara L RasmussenDepartment of Molecular Physiology, Baylor College of Medicine, Houston, TX 77030, USA.
Haley O TuckerDepartment of Molecular Biosciences, Institute for Cellular Molecular Biology, The University of Texas at Austin, Austin, TX 78712, USA.
Robert J SchwartzDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA Stem Cell Engineering Department, Texas Heart Institute at St Luke's Episcopal Hospital, Houston, TX 77030, USA.
University of Houston · USSt. Luke's Episcopal Hospital · USBaylor College of Medicine · USThe University of Texas at Austin · USUniversity of Houston - Downtown · US

Funding

Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI VALLABH E DAS · 1988 to 2026
$16.4M
NEI NIH HHS P30 EY007551NEI NIH HHS P30EY007551
6 · The paper itself

Abstract

The Smyd1 gene encodes a lysine methyltransferase specifically expressed in striated muscle. Because Smyd1-null mouse embryos die from heart malformation prior to formation of skeletal muscle, we developed a Smyd1 conditional-knockout allele to determine the consequence of SMYD1 loss in mammalian skeletal muscle. Ablation of SMYD1 specifically in skeletal myocytes after myofiber differentiation using Myf6(cre) produced a non-degenerative myopathy. Mutant mice exhibited weakness, myofiber hypotrophy, prevalence of oxidative myofibers, reduction in triad numbers, regional myofibrillar disorganization/breakdown and a high percentage of myofibers with centralized nuclei. Notably, we found broad upregulation of muscle development genes in the absence of regenerating or degenerating myofibers. These data suggest that the afflicted fibers are in a continual state of repair in an attempt to restore damaged myofibrils. Disease severity was greater for males than females. Despite equivalent expression in all fiber types, loss of SMYD1 primarily affected fast-twitch muscle, illustrating fiber-type-specific functions for SMYD1. This work illustrates a crucial role for SMYD1 in skeletal muscle physiology and myofibril integrity.

Indexed as

AnimalsCell NucleusDNA-Binding ProteinsFemaleMaleMice, KnockoutMuscle DevelopmentMuscle Fibers, Fast-TwitchMuscle ProteinsMuscle StrengthMuscular AtrophyMyofibrilsOrgan SizeOxidation-ReductionRegenerationSarcolemmaDNA-Binding ProteinsMuscle ProteinsSmyd1 protein, mouseTranscription FactorsDevelopmentGeneticsMethylationMuscleMyocyteMyopathySMYD1

Identifiers

PMID26935107
PMCPMC4833328
OpenAlexW2299885710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.